CLX vs IRMD · P/E 15, rev $7.10B vs P/E 51, rev $42.4M
The Clorox Company (CLX) versus Iradimed Co (IRMD) — a side-by-side from cached financials, not a winner call.
The Clorox Company (CLX) is a household & personal products company listed on US.
Iradimed Co (IRMD) is a medical devices company listed on US.
Latest reported CLX revenue for 2025-06-30 was $7.10B. Net income was $824.0M. CLX currently screens at market cap $10.89B and trailing P/E 14.6.
Latest reported IRMD revenue for 2026-06-30 was $42.4M. Net income was $11.0M. Revenue was up 93.1% from 2026-03-31 to 2026-06-30. IRMD currently screens at market cap $1.19B and trailing P/E 50.9.
CLX currently screens at market cap $10.89B and trailing P/E 14.6. IRMD currently screens at market cap $1.19B and trailing P/E 50.9.
Not investment advice. Open the CLX and IRMD stock pages for the full models.
Not investment advice.